Table 3 Table a1

From: Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review

 

Weight loss (kg)

BMI loss (kg/m2)

Conversion factor

McMahon89

4.4

1.6

0.364

McMahon90

4.5

1.6

0.356

Smith and Goulder66

6.5

2.4

0.369

Mean

  

0.363

Sub-group

Units/BMI

Units/kg

% vs sibutramine

Sibutramine

—

0.00375

100

Orlistat (non-diabetics)

0.017

0.00617 (imputed)

164

Orlistat (diabetics)

0.028

0.01016 (imputed)

271

Back to article page